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Studies from a number of laboratories have shown that vitamin C deficiency 
in guinea pigs results in decreased metabolism of a variety of pharmacological 
agents.'-'" In 1941, Richards et al.' found a prolonged sleeping time in scorbutic 
guinea pigs given pentobarbital compared with that of normal animals, and the 
administration of ascorbic acid reversed the effect. Axelrod et a1.j in 1954 
reported up to a threefold increase in plasma half-life of such agents as acetani- 
lid, aniline, or antipyrine in guinea pigs depleted of vitamin C that was attributed 
to lowered rates of metabolism. In addition, the increase in plasma half-life of 
these agents could be reversed in 4 to 6 days if the diet was replenished with 
ascorbic acid. Other laboratories 6, i have reported decreased oxidation of such 
agents as zoxazolamine, acetanilid, coumarin, diphenylhydramine, and meperi- 
dine in microsomes prepared from scorbutic guinea pigs. Our current knowledge 
of the hepatic electron transport system involving NADPH, cytochrome P-450 
reductase, cytochrome P-450, and molecular oxygen required for the mixed- 
function oxygenase-type drug hydroxylation reactions has allowed a more direct 
approach in studies on the effect of ascorbic acid in the oxidation of a variety 
of pharmacological agents. 
Results 
If groups of adult guinea pigs weighing 250-400 grams were maintained on 
a vitamin-C-deficient diet for 21 days, the hydroxylation of aniline, aminopyrine, 
and p-nitroanisole as well as the quantity of cytochrome P-450 and cytochrome 
P-450 reductase was significantly decreased: the liver microsomal ascorbic acid 
was 30% of normal; the animals had lost at most 5% of their body weight and 
were not frankly scorbutic. On the other hand, if adult guinea pigs were 
maintained on a vitamin-C-deficient diet for only 10 days, there was no signifi- 
cant difference in drug metabolism (TABLE 1) .  In addition, study of groups of 
fasted guinea pigs that had lost up to 30% of their body weight indicated that 
the decreased drug metabolism observed in the 21 -day vitamin-C-deficient ani- 
mals could not be due to the weight loss observed in this group (5% ) since in 
the starved animals drug metabolism was either normal or increased two- to 
threefold." These studies as well as those from other laboratories were done in 
the main with adult guinea pigs severely depleted of ascorbic acid.5* 7, 8 ,  In, l8 
It was, therefore, important to determine if weanling guinea pigs (90 to 100 g 
* This study was supported by Grant 17184 from the National Institutes of Health, 
United States Public Health Service and Grant 23007 from Hoffmann-LaRoche, Inc. 
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and 1 to 2 weeks of age) placed on a vitamin-C-deficient diet for a relatively 
short period (8 or 15 days) would be more dependent on the vitamin to main- 
tain adequate drug metabolism, since they are in their rapid period of growth. 
In addition, weanling guinea pigs were given high supplements of vitamin C 
(up to 75  mg per day) to observe what effect excess ascorbic acid, well beyond 
the recommended daily requirement, would have on the liver microsomal-drug- 
metabolizing system. The data in FIGURE 1 illustrate the increasing pattern of 
activity of NADPH-cytochrome P-450 reductase in groups of weanling guinea 
pigs on a deficient diet for 15 days (point l ) ,  those on a deficient diet for 8 
days, and those given extra ascorbic acid, up to 75 mg per day. The activity 
of NADPH-cytochrome P-450 reductase increased almost threefold over that 
of 15-day-vitamin-C-deficient animals when the liver ascorbic acid concentration 
was 27.0 mg/100 g liver; there was a twofold increase over that of &day 
deficient animals. A similar pattern of increase in the quantity of cytochrome 
P-450 was found with increasing in vivo administration of ascorbic acid but 
was smaller in magnitude. At a liver ascorbic acid concentration of 27 mg/ 100 
TABLE 1 
AND ELECTRON-TRANSPORT COMPONENTS IN GUINEA PIG LIVER MICROSOMES 
EFFECT OF VITAMIN C DEFICIENCY (10 AND 21 DAYS) ON DRUG ENZYMES 
Activity * 
Vitamin& Vitamin-C- De- 
Normal (10 Days) (21 Days) (%) 
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* Activity of aniline hydroxylase, aminopyrine, N-demethylase, and p-nitroanisole, 
0-demethylase equals pmoles of product formed/hr/ 100 mg of microsomal protein 
at 27". Cytochrome P-450 equals pmoles/100 mg microsomal protein; NADPH cy- 
tochrome P-450 reductase equals pmoles reduced/hr/ 100 mg microsomal protein at 
27" C. Mean -C SE of 10 animals per group? 
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FIGURE 1. NADPH-cytochrome P-450 reductase activity in weanling guinea pigs 
given varying amounts of ascorbic acid. Specific activity is expressed as *moles 
cytochrome P-450 reduced/hr/lOO mg of microsomal protein at 27". The number of 
animals in each group is given in the FIGURE. The diets of the various groups con- 
tained: (1) less than 1.0 mg ascorbic acid/100 g liver, ascorbic-acid-deficient diet 
for 15 days; (2 )  2.3 mg ascorbic acid/100 g liver, ascorbic-acid-deficient diet for 
8 days; (3 )  7.4 rng ascorbic acid/100 g liver, 25 mg day of ascorbic acid given for 
8 days; (4) 13.5 mg ascorbic acid/100 g liver, 75 mg day of ascorbic acid given for 
8 days; and (5) 27.0 mg ascorbic acid/100 g liver, chow guinea pig diet plus greens 
given 8 days. (From Sato and Zannoni.'" By permission of Biochemical Pharma- 
cology.) 
g there was 0.068 pmoles of cytochrome P-450/ 100 mg of microsomal protein 
as against 0.047 in animals on a deficient diet for 15 days. The data in FIGURE 
2 show a substantial increase in p-nitroanisole 0-demethylase activity with 
increasing administration of ascorbic acid to weanling guinea pigs. There was 
a fourfold increase in 0-demethylation at a liver ascorbic acid concentration 
of 27 mg per 100 g over that of the 15-day-deficient group (liver ascorbic 
acid; <1.0 mg/100 g liver) and approaching a twofold increase over that of 
the 8-day deficient group (liver ascorbic acid; 2.7 mg/100 g liver). A similar 
pattern of increase was observed in N-demethylase activity but was not as 
striking as that observed with 0-demethylation. There was a 60% increase in 
the N-demethylation of aminopyrine in animals with a liver ascorbic acid con- 
centration of 27 mg/ 100 g over that of the 15-day deficient group. It should be 
mentioned that the body weights of the animals on a deficient diet for 8 or 
1.5 days did not significantly differ from the body weights of the control groups 
of animals, i.e., normal chow diet supplemented with greens 3 times a week. 
Also, there was no signs of scurvy in the &day deficient group, while some of 
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FIGURE 2. p-Nitroanisole 0-demethylase activity in weanling guinea pigs given 
varying amounts of ascorbic acid. Specific activity is expressed as pmoles p-nitro- 
phenol formed/hr/100 rng of microsomal protein at 27". The number of animals in 
each group is shown in the figure. The diets of the various groups contained: (1) 
less than 1.0 rng ascorbic acid/100 g liver, ascorbic-acid-deficient diet given for 15 
days; (2 )  2.7 rng ascorbic acid/100 g liver, ascorbic-acid-deficient diet given for 
8 days; (3)  13.5 mg ascorbic acid/100 g liver 75 mg/day of ascorbic acid given 
for 8 days; and (4) 27.0 rng ascorbic acid/100 g liver, chow guinea pig diet plus 
greens given for 8 days. (From Sato and Zannoni.'' By permission of Biocliernicul 
Pharmacology. ) 
the animals in the IS-day deficient group had moderate joint hemorrhages. It 
should be noted that there was no  significant difference in the amount of 
decreased drug-metabolizing enzyme activites in the 1 5-day deficient animals 
with or without hemorrhages. 
Further studies with fetal guinea pig livers indicated a marked variation 
in cytochrome P-450 and 0-demethylase activity in individual fetal livers, 
which correlated well with the concentration of liver ascorbic acid (TABLE 2). 
Fetal livers with an ascorbic acid concentration of below 5.0 mg/100 g liver 
had no detectable cytochrome P-450 or 0-demethylase activity while fetal livers 
with high ascorbic acid levels (above 17.0 rng/100 g liver) had much higher 
drug metabolism activity; cytochrome P-450 concentration, 84% of the dams; 
and 0-demethylase activity, 51 % of the dams. 
Specificity studies were carried out to determine if other reducing agents, 
such as reduced 2,6-dichlorophenolindophenoI dye, reduced glutathione, and 
D-isoascorbic acid, would be effective in increasing overall liver microsomal 
drug-metabolizing reactions. These compounds were fed to groups of weanling 
guinea pigs on an ascorbic-acid-deficient diet for 8 days. In  addition, ascorbyl 
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palmitate, a more lipophilic analogue of ascorbic acid, was used to determine 
if it  would be more effective than ascorbic acid in increasing drug-metabolism 
activities (TABLE 3 ) .  Reduced 2,6-dichlorophenolindophenol dye ( 2  mg/day) 
did not significantly affect the liver microsomal levels of cytochrome P-450 and 
NADPH cytochrome P-450 reductase or the overall microsomal drug-oxidation 
reaction, p-nitroanisole 0-demethylation. Aminopyrine N-demethylation, how- 
ever, was somewhat increased compared with that of the deficient groups. The 
administration of reduced glutathione to  guinea pigs (10 mg/day) did not 
significantly alter liver microsomal cytochrome P-450 concentration or p 
nitroanisole 0-demethylase activity from those values in 8-day ascorhic-acid- 
deficient animals. There was, however, an increase in aminopyrine N-demethy- 
lase activity in this group and an increase of 59% in NADPH cytochrome P-450 
reductase activity over the activities in %day vitamin-C-deficient guinea pigs. 
misoascorbic acid (200 mg/day)  was not effective in increasing either drug- 
metabolism activities or electron-transport components. In comparison, ascorbyl 
palmitate was more effective in increasing levels of electron transport coni- 
ponents and overall drug-oxidation reactions. Administration of 50 mg/day, 
0.12 mM, led to a liver ascorbic acid concentration of 10.8 m g % ,  whereas 
administration of 0.3 1 mM of ascorbic acid was required to obtain a comparable 
liver ascorbic acid concentration, i.e., 13.5 m g % .  The concentration of cyto- 
chrome P-450 was as high as that in the group of animals on a normal chow 
diet. 
Reversal of decreased drug metabolism activities in vitamin-C-deficient ani- 
mals by the in v ivo  administration of ascorbic acid indicated that, although the 
quantity of liver ascorbic acid was restored t o  normal levels within 3 days, most 
of the drug enzyme activities required 6 to  10 days of ascorbic acid administra- 
tion to  return to  normal. Aniline hydroxylase activity required from 3 to 6 
days, while aminopyrine N-demethylase and p-nitroanisole 0-demethylase ac- 
tivities returned to  normal levels within 6 to 10 days (FIGURE 3 ) .  Microsomal 
electron transport components, such as cytochrome P-450 and NADPH cyto- 
chrome P-450 reductase, also returned to  normal levels within 6 to 10 days 
(FIGURE 4) .  
TABLE 2
IN FETAL GUINEA PIG LIVERS 
CYTOCHROME P-450, 0-DEMETHYLASE AND ASCORBIC ACID LEVELS 
0-Demethylase 
pmoles Product 
P-450 Formed/hr/ 100 mg 
Ascorbic Acid prnoles/100 mg Microsomal Protein 
mg/ 100 g Liver Microsomal Protein at 27" 
fetal (2):$ 
fetal ( 3 ) *  
fetal (4)" 
dam (3) 
4.5 < 0.001 < 0.01 
11.2 0.004 0.1 1 
17.5 0.011 0.78 
21.7 0.0 13 1.73 
* 64-66 days of gestation, number in parentheses equals numbers of animals; av- 
erage values given; ascorbic acid determined by method of Zannoni et al."' Individual 
values in groups did not differ by more than 12%. 
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FIGURE 3. Reversal of decreased aniline hydroxylase, aminopyrine N-demethylase, 
and p-nitroanisole 0-demethyalse activities in vitamin-c-deficient guinea pigs with 
ascorbic acid. Groups of normal and vitamin-C-deficient guinea pigs (21 days) were 
given 50 mg of ascorbic acid in their drinking water for 3, 6 and 10 days. Enzyme 
activity equals the micromoles product formed per hours per 100 mg liver micro- 
soma1 protein at 27". (From Zannoni ei By permission of Biochemical Pharma- 
cology. 
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FIGURE 4. Reversal of decreased electron-transport components in vitamin-C- 
deficient guinea pigs with ascorbic acid. Groups of normal and vitamin-C-deficient 
guinea pigs ( 2 1  days) were given 50 mg of ascorbic acid in their drinking water for 
3, 6 and 10 days. The quantity of cytochrome b, equals the micromoles per 100 mg 
liver microsomal protein. NADPH cytochrome P-450 reductase equals the micro- 
moles of cytochrome P-450 reduced per hour per 100 mg liver microsomal protein 
at 27". NADPH cytochrome c reductase equals the micromoles of cytochrome c re- 
duced per hour per 100 mg liver microsomal protein at 27". Cytochrome P-450 
equals the micromoles per 100 mg liver microsomal protein. (From Zannoni et a/." 
By permission of Biochemical Pharmacology.) 
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Other studies using phenobarbital indicated that overall drug oxidation ac- 
tivites (aniline hydroxylase, aminopyrine M-demethylase, and p-nitroanisole 0- 
demethylase) and microsomal electron transport components were induced in 
vitamin-C-deficient guinea pigs comparable to that found in normal animals 
(TABLE 4). Aniline hydroxylase increased 2.1-fold in the vitamin-C-deficient 
animal as against 1.4-fold in the normal animal, and p-nitroanisole O-demethy- 
lase increased 5.9-fold in the vitamin-C-deficient animal compared to 3.5-fold 
in the normal animal. Furthermore, the difference between the level of activity 
after phenobarbital treatment and basal level (no treatment) in vitamin-(=- 
TABLE 3 
DRUG METABOLISM, I n  Yivo 
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Treatment: Groups of weanling guinea pigs were fed on a chow guinea pig diet 
supplemented with greens and an eight-day ascorbic-acid-deficient guinea pig diet. 
Reduced 2,6-dichlorophenolindophenol dye, 2 mg/day, given to guinea pigs on 
ascorbic-acid-deficient diet, treated for 8 days. Reduced glutathione, 10 mg/day, 
given to guinea pigs on ascorbic-acid-deficient diet, treated for 8 days. D-isoascorbate, 
200 mg/day, given to guinea pigs on ascorbic-aciddeficient diet, treated for 8 days. 
Ascorbyl palmitate, 50 mg/day, supplemented to guinea pigs on ascorbic-acid- 
deficient diet, treated for 8 days.% 
t Activities of cytochrome P-450, P-450 reductase, 0-demethylase and N-demethyl- 
ase equals pmoles of product formed/hr/100 mg of microsomal protein at 27" C. 
deficient and normal guinea pigs was in the same order of magnitude for each 
enzyme activity. The individual electron-transport components were also in- 
duced in vitamin-C-deficient guinea pigs and the fold increase was equivalent 
to, or in some cases better than, that of normal guinea pigs. 
It was of interest to determine if changes in kinetic constants occurred in 
weanling guinea pigs made vitamin-C-deficient or, more important, if any altera- 
tion in the apparent affinity occurred in animals under conditions of increased 
drug-metabolism activities, such as when large amounts of ascorbic acid were 
administered. Apparent affinity constants of aminopyrine N-demethylase were 
determined with microsomes isolated from 8- and 15-day-deficient animals, 
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animals receiving 50 or 500 mg per day of ascorbic acid for  8 days, and in 
guinea pigs given a normal diet of chow pellets. Under these conditions the 
animals had decreased as well as increased drug enzyme activity. FIGURE 5 
gives the kinetic data from which the K,, of liver microsomal aminopyrine N- 
demethylase was calculated for 8- and 15-day ascorbic-acid-deficient animals, 
and for  animals given the normal diet, In contrast to  the differences in amino- 
pyrine N-demethylase activities found in these groups, the Michaelis-Menten 
affinity constants were not significantly altered. The K,, value for normal 
weanling guinea pigs was 1.67 x 1 CF M. Eight- and 15-day-deficient animals 
had K,, values of 1.67 x lo-,< M, and 1.89 X lo-:{ M respectively. FIGURE 6
gives the kinetic data from which the K,, of liver microsomal aminopyrine 
Chow Dirt 
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FIGURE 5 .  Apparent KM of liver microsomal aminopyrine N-demethylase activity 
in weanling guinea pigs on various ascorbic acid regimens. On chow diet plus greens 
liver ascorbic acid is 27 mg/100 g liver. On 8-day ascorbic-acid-deficient diet liver 
ascorbic acid is 2 mg/100 g liver. On 15-day ascorbic-acid-deficient diet liver ascorbic 
acid is less than 1 mg/100 g liver. 
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TABLE 4
PHENOBARBITAL INDUCTION OF DRUG ENZYMES AND ELECTRON-TRANSPORT 
COMPONENTS IN NORMAL AND VITAMIN-C-DEFICIENT GUINEA PIGS 
Activity * 
Normal Vi tamin-C-Deficient 
Fold Fold 
No R, PB R,i Increase No R, PB R,t Increase 
Aniline hydroxylase 1.6 2.3 1.4 0.8 1.7 2.1 
Arninopyrine N-demethylase 3.9 9.6 2.5 1.7 7.6 4.5 
p-Nitroanisole Odemethylase 3.2 11.1 3.5 1.1 6.5 5.9 
Cytochrome P-450 0.05 0.11 2.2 0.03 0.06 2.0 
NADPH P-450 reductase 0.8 2.6 3.3 <0.10 2.8 28.0 
NADPH cytochrorne c 
reductase 124 288 2.3 83 250 3.0 
Cytochrome b; 0.03 0.03 1.0 0.02 0.02 1.0 
* Activity equals prnoles of product formed/hr/lOO mg of microsomal protein at 
27" C. Liver ascorbic acid:norrnal induced, 195 pg/g wet weight (15,OOo~g super- 
natant fraction), 19 pg/g wet weight (microsomal fraction) ; Vitamin-Cdeficient 
induced, 71 pg/g wet weight (15,OOOxg supernatant fraction), 5 pg/g wet weight 
(microsomal fraction) .' 
t Phenobarbital treatment: guinea pigs received 1 mg sodium phenobarbital/ml for 
4 days in drinking water; 30 to 40 ml consumed per day. 
N-demethylase was calculated for weanling guinea pigs given 50 mg and 500 
mg ascorbic acid per day for 8 days, and for animals maintained on a normal 
chow diet. As can be observed, there was no significant difference in these 
values. The K,, value for animals given 50.0 mg per day of ascorbic acid was 
1.57 X lo-" M. Animals receiving 500 mg per day of ascorbic acid for the 
8-day period had an affinity constant of 1.85 X lo-" M. The K,, value of 
aminopyrine N-demethylase in weanling guinea pigs given a chow diet was 
1.67 x lo-'< M. Similar results were obtained in kinetic studies with O-demethy- 
lase in that there was no significant alteration in the K,, constants for this 
enzyme system. 
Conclusions and Summary 
Both in vivo and in vitro investigations from several laboratories have shown 
that vitamin-C deficiency results in decreased metabolism of a variety of phar- 
macological agents. These studies have demonstrated that 0-demethylation, N- 
demethylation, and hydroxylation reactions as well as individual liver micro- 
soma1 electron transport components such as cytochrome P-450 and NADPH 
cytochrome P-450 reductase are decreased in guinea pigs depleted of ascorbic 
acid. In addition, the decreased drug enzyme activities can be restored to 
normal levels if the deficient animals are given the vitamin for a period of 6 
to 10 days. The majority of these previous studies were carried out in adult 
guinea pigs (250-400 g) maintained on a deficient diet for a substantial length 
of time, up to 21 days. 
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Our more recent studies include the effect of ascorbic acid on drug metabo- 
lism in weanling animals maintained for a short period on a vitamin-C-deficient 
diet (8-1 5 days) ; these animals were used since they are in their rapid growth 
period and are more susceptible to a vitamin deficiency. Importantly, these 





Km = 1.67 x IO-’M 
-0.6 -0.2 0 0.2 0.6 1.0 1.4 
50mg/day, Ascorbic Acid 




I I I I I I I I  
-0.6 -0.2 0 0.2 0.6 1.0 1.4 
5 0 0 m g / d o y ,  Ascorbic  Acid 




I I  I I I I l l l I l  
-0.6 -0.2 0 0.2 0.6 1.0 1.4 
1 
Aminopyrine,mM 
FIGURE 6. Apparent KM of liver microsomal aminopyrine N-demethylase activity 
in weanling guinea pigs on various ascorbic acid regimens. On chow diet plus greens 
liver ascorbic acid is 27 mg/100 mg liver. On 50 mg per day ascorbic acid for 8 days 
liver ascorbic acid is 9.9 mg/100 g liver. On 500 mg per day ascorbic acid for 8 
days liver ascorbic acid is 23.3 mg/100 g liver. 
studies indicate that not only does deficiency result in decreased drug metabo- 
lism, but also the activity of the microsomal drug oxidation system increases 
over basal levels when the animals are given high supplements of the vitamin. 
NADPH cytochrome P-450 reductase, N-demethylase, and 0-demethylase ac- 
tivities increased as much as 200% while the increase in the quantity of cyto- 
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chrome P-450 was smaller and indicates that the cytochrome may not be rate- 
limiting with respect to the effect of ascorbic acid. In contrast, cytochrome 
P-450 reductase activity markedly increased and showed a greater dependence 
on the liver concentration of ascorbic acid since the increases observed corre- 
lated well with the amount of ascorbic acid present in  the liver. Furthermore, 
our studies with fetal guinea pig liver indicate a marked reduction in overall 
drug metabolism reactions and quantity of electron-transport components in 
liver with low concentrations of ascorbic acid. Comparison of drug metabolism 
activities with liver ascorbic acid concentrations in individual fetal livers showed 
a significant correlation of drug metabolism ability and ascorbic acid concen- 
tration. Some of the delayed appearance of drug-enzyme activity known to 
occur in prenatal guinea pigs could be due, in  part, to the amount of ascorbic 
acid present in the fetal liver. It would be of interest to compare various drug 
and steroid hydroxylation systems at various times of gestation during the fetal 
life of the guinea pig with ascorbic acid levels as well as with the changes in 
the hepatic smooth endoplasmic reticulum in the developing fetus.11. l2 With 
respect to this, protein synthesis involved in the electron-transport system in 
the adult guinea pig is not affected in vitamin-C deficiency in that induction 
occurs with phenobarbital to the same extent as in normal animals.3 
Specificity s1:udics with analogues of ascorbic acid indicate that the stimula- 
tion of drug enzyme activities occurs with such compounds as misoascorbic 
acid or ascorbyl palmitate. However, much higher amounts of misoascorbic 
acid were required than of the vitamin, which can be explained in part by the 
difficulty in obtaining liver concentrations of the D-isomer equivalent to those 
of vitamin C, since the former is rapidly excreted by the kidney. On the other 
hand, ascorbyl palmitate, a more lipophilic compound than the vitamin, was 
as effective as ascorbic acid on a molar basis. 
To date, our studies:i as well as those of other investigators,h.13 have indi- 
cated that the quality as well as the quantity of the cytochrome P-450 is altered 
in vitamin-C-deficient microsomes. Both type I and type I1 substrate binding 
spectra are atypical, with microsomes isolated from vitamin-C-deficient animals 
in that the peak, trough, and magnitude of absorption are altered. Changes in 
cytochrome P-450 substrate binding spectra may indicate an alteration in the 
structure of the hemeprotein. For that matter, the atypical binding spectra in 
vitamin-C-deficient guinea pig microsomes may reflect an alteration in the 
essential phospholipid moiety needed for functioning cytochrome P-450. 
Further in vitro studies on the purification and separation of individual 
microsomal electron-transport components from normal and vitamin-C-deficient 
livers will be helpful in ascertaining a more precise biochemical understanding 
of the function of ascorbic acid in drug metabolism. Qualitative physical- 
chemical differences in addition to quantitative differences in electron-transport 
components such as cytochrome P-450, differences in substrate P-450 binding, 
and possible alteration in the important microsomal phospholipid moiety could 
be investigated. In addition, kinetic studies with the component partial reac- 
tions involved in drug hydroxylation would be helpful in determining any 
stoichiometric requirements of ascorbic acid for maximum drug hydroxylation 
as well as any interaction of ascorbic acid with particular microsomal com- 
ponents. Concomitant with these studies, experiments concerned with the syn- 
thesis and degradation of cytochrome P-450 or an altered form of the cyto- 
chrome as well as studies o n  the turnover of the essential phospholipid 
associated with the microsomal electron-transport system in normal and vitarnin- 
C-deficient guinea pigs would be of interest. 
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The requirement of vitamin C in the metabolism of drugs in man may be 
of clinical importance, especially in the young. In this respect the recommended 
amount of the vitamin, 70-75 mg per day l4 may not be adequate for optimum 
activity of the microsomal drug enzymes, especially if a n  increased formation 
of metabolites followed by subsequent conjugation reactions are necessary to 
ensure efficient detoxification. It would be  of interest to  determine if increased 
intake of ascorbic acid in man, above the daily recommended requirements, 
would decrease the biological plasma half-life of a variety of commonly used 
drugs. 
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DISCUSSION 
DR. 1. B. CHATTERJEE: Did you measure the enzyme activity in the super- 
natant fraction to see if the enzymes are released? Your work indicates that 
it takes about 7-10 days for the reversal. That means that during this time, 
btructural integrity is again gained. 
DR. V. ZANNONI: We looked at the supernatant in terms of release, espe- 
cially in the animals that were 3 weeks scorbutic. There was no indication of 
activity there. I agree that a structural change may occur. With prototype 
drugs, such as aniline, a type-I1 binder, we obtain a definite alteration in the 
binding spectrum that can be reversed with compounds like ascorbyl palmitate. 
So, a structural alteration may really occur, which then affects the metabolism. 
We’re certainly interested in the phosphatidyl choline portion of the lipid 
portion of the microsomes. We looked at lipid peroxidation to see if it increased 
or decreased with deficiency, and it remained the same. 
DR. A. E. KITABCHI: In regard to the specificity of the organ, have you 
studied the steroid 21-hydroxylase in guinea pigs? Second, if induction is 
blocked by either actinomycin or cycloheximide, in bovine adrenal microsomes, 
ascorbic acid has no stimulating effects on the 21 -hydroxylase system. 
DR. ZANNONI: We didn’t test the 21-hydroxylase. 1 think Dr. Avenia and 
Dr. Kamm studied steroid hydroxylation in deficiency. As I recall, they found 
a decrease in activity in steroid hydroxylation. We don’t think that the increase 
we observed with increased vitamin C is due to induction in the sense of protein 
synthesis; rather, we think it’s a protection or reduction of something on the 
membrane or protection against an alteration. We are not looking at this as 
phenobarbital induction. There is no evidence of this phenomenon. The vitamin- 
C-deficient animal can induce the same-fold increase as a normal animal in 
terms of protein synthesis. 
QUESTION: Do you believe that cytochrome c is an appropriate acceptor 
for the NADPH reductase system? 
DR. ZANNONI: Cytochrome c is used because of its availability as an electron 
acceptor. 
DR. W. B. SMITH: Have you tried other reducing agents? 
DR. ZANNONI: Yes, we’ve used glutathione, the 2,6 dye, isoascorbate, and 
ascorbyl palmitate. 
